Analysis Metabolite Name Measured Value Units Group
Reversed phase POSITIVE ION MODEazelate (C9-DC)0.3891Peak areaLean
Reversed phase POSITIVE ION MODEazelate (C9-DC)0.3891Peak areaObese neuropathy
Reversed phase POSITIVE ION MODEazelate (C9-DC)0.3891Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODEazelate (C9-DC)0.4089Peak areaObese neuropathy
Reversed phase POSITIVE ION MODEazelate (C9-DC)0.4296Peak areaObese neuropathy
Reversed phase POSITIVE ION MODEazelate (C9-DC)0.4761Peak areaObese neuropathy
Reversed phase POSITIVE ION MODEazelate (C9-DC)0.5236Peak areaLean
Reversed phase POSITIVE ION MODEazelate (C9-DC)0.5479Peak areaLean
Reversed phase POSITIVE ION MODEazelate (C9-DC)0.5650Peak areaLean
Reversed phase POSITIVE ION MODEazelate (C9-DC)0.5851Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODEazelate (C9-DC)0.5956Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODEazelate (C9-DC)0.6254Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODEazelate (C9-DC)0.6339Peak areaLean
Reversed phase POSITIVE ION MODEazelate (C9-DC)0.6395Peak areaLean
Reversed phase POSITIVE ION MODEazelate (C9-DC)0.6605Peak areaObese neuropathy
Reversed phase POSITIVE ION MODEazelate (C9-DC)0.6706Peak areaObese neuropathy
Reversed phase POSITIVE ION MODEazelate (C9-DC)0.6778Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODEazelate (C9-DC)0.7176Peak areaLean
Reversed phase POSITIVE ION MODEazelate (C9-DC)0.7180Peak areaLean
Reversed phase POSITIVE ION MODEazelate (C9-DC)0.7313Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODEazelate (C9-DC)0.7497Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODEazelate (C9-DC)0.7712Peak areaObese neuropathy
Reversed phase POSITIVE ION MODEazelate (C9-DC)0.7785Peak areaLean
Reversed phase POSITIVE ION MODEazelate (C9-DC)0.8027Peak areaLean
Reversed phase POSITIVE ION MODEazelate (C9-DC)0.8443Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODEazelate (C9-DC)0.8597Peak areaObese neuropathy
Reversed phase POSITIVE ION MODEazelate (C9-DC)0.8634Peak areaLean
Reversed phase POSITIVE ION MODEazelate (C9-DC)0.8687Peak areaObese neuropathy
Reversed phase POSITIVE ION MODEazelate (C9-DC)0.8747Peak areaLean
Reversed phase POSITIVE ION MODEazelate (C9-DC)0.8822Peak areaLean
Reversed phase POSITIVE ION MODEazelate (C9-DC)0.8857Peak areaObese neuropathy
Reversed phase POSITIVE ION MODEazelate (C9-DC)0.8914Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODEazelate (C9-DC)0.9360Peak areaLean
Reversed phase POSITIVE ION MODEazelate (C9-DC)0.9396Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODEazelate (C9-DC)0.9686Peak areaObese neuropathy
Reversed phase POSITIVE ION MODEazelate (C9-DC)0.9713Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODEazelate (C9-DC)0.9923Peak areaLean
Reversed phase POSITIVE ION MODEazelate (C9-DC)1.0000Peak areaLean
Reversed phase POSITIVE ION MODEazelate (C9-DC)1.0861Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODEazelate (C9-DC)1.1461Peak areaObese neuropathy
Reversed phase POSITIVE ION MODEazelate (C9-DC)1.1669Peak areaObese neuropathy
Reversed phase POSITIVE ION MODEazelate (C9-DC)1.1918Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODEazelate (C9-DC)1.2168Peak areaObese neuropathy
Reversed phase POSITIVE ION MODEazelate (C9-DC)1.2263Peak areaObese neuropathy
Reversed phase POSITIVE ION MODEazelate (C9-DC)1.2569Peak areaLean
Reversed phase POSITIVE ION MODEazelate (C9-DC)1.2633Peak areaLean
Reversed phase POSITIVE ION MODEazelate (C9-DC)1.2724Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODEazelate (C9-DC)1.3015Peak areaLean
Reversed phase POSITIVE ION MODEazelate (C9-DC)1.3205Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODEazelate (C9-DC)1.3942Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODEazelate (C9-DC)1.4070Peak areaLean
Reversed phase POSITIVE ION MODEazelate (C9-DC)1.4479Peak areaObese neuropathy
Reversed phase POSITIVE ION MODEazelate (C9-DC)1.4781Peak areaLean
Reversed phase POSITIVE ION MODEazelate (C9-DC)1.5020Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODEazelate (C9-DC)1.5254Peak areaLean
Reversed phase POSITIVE ION MODEazelate (C9-DC)1.5608Peak areaObese neuropathy
Reversed phase POSITIVE ION MODEazelate (C9-DC)1.6149Peak areaLean
Reversed phase POSITIVE ION MODEazelate (C9-DC)1.7524Peak areaObese neuropathy
Reversed phase POSITIVE ION MODEazelate (C9-DC)1.7603Peak areaLean
Reversed phase POSITIVE ION MODEazelate (C9-DC)1.7792Peak areaLean
Reversed phase POSITIVE ION MODEazelate (C9-DC)1.7893Peak areaObese neuropathy
Reversed phase POSITIVE ION MODEazelate (C9-DC)1.9575Peak areaLean
Reversed phase POSITIVE ION MODEazelate (C9-DC)2.2489Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODEazelate (C9-DC)2.2597Peak areaObese neuropathy
Reversed phase POSITIVE ION MODEazelate (C9-DC)2.3964Peak areaObese neuropathy
Reversed phase POSITIVE ION MODEazelate (C9-DC)2.7244Peak areaLean
Reversed phase POSITIVE ION MODEazelate (C9-DC)2.7862Peak areaObese neuropathy
Reversed phase POSITIVE ION MODEazelate (C9-DC)2.9143Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODEazelate (C9-DC)3.3530Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODEazelate (C9-DC)3.3578Peak areaObese neuropathy
Reversed phase POSITIVE ION MODEazelate (C9-DC)3.7961Peak areaObese neuropathy
Reversed phase POSITIVE ION MODEazelate (C9-DC)4.9760Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODEazelate (C9-DC)126.6679Peak areaObese non neuropathy

Return to search page
  logo